TY - JOUR T1 - Drug-drug interactions during antiviral therapy for chronic hepatitis C JF - Nat Rev Gastroenterol Hepatol Y1 - 2013 A1 - Kiser, J.J. A1 - J R Burton Jr. A1 - G.T. Everson KW - Antiviral Agents KW - boceprevir KW - Colorado KW - Drug Interactions KW - Genotype KW - genotype 1 KW - HCV KW - hepatitis KW - Hepatitis C KW - Infection KW - NS5A inhibitor KW - P-Glycoprotein KW - Pharmacies KW - pharmacology KW - Pharmacy KW - protease inhibitor KW - Protease Inhibitors KW - Research KW - Research Support KW - Ribavirin KW - sustained virologic response KW - Telaprevir KW - therapy KW - toxicity KW - treatment VL - 10 SP - 596-606 IS - 10 ER -